Ciprofloxacin Tablet, Film Coated
Product Images NDC 55154-0193
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin (NDC 55154-0193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (58c0f4b8 D6bc 48f1 86db D4db3eee2249 03)
500mg Bag Label (922e9f5c Cc59 4d9e Bf42 A4b900d077ed 00)
This is a description of Ciprofloxacin tablets containing 500 mg of the active ingredient. The tablets are used for various medical conditions, with detailed dosage and administration instructions provided in the product insert. It is important to store the tablets within the recommended temperature range and keep them out of reach of children, as the packaging is not child-resistant. The medication guide should be dispensed by the pharmacist. The tablets are manufactured by Unique Pharmaceutical Laboratories in India and distributed by Rising Pharma Holdings, Inc. in East Brunswick, NJ. The overall packaging and distribution are handled by Majors Pharmaceuticals in Indianapolis, Indiana, and Cardinal Health in Dublin, Ohio.*
Adult Dosage Guidelines (Adult Dosage Guidelines)
This text provides information about the recommended dosage, frequency, and duration for various bacterial infections, including skin and skin structure infections, bone and joint infections, intra-abdominal infections, infectious diarrhea, typhoid fever, anthrax, plague, urinary tract infections, and others. It specifies the specific dosage in milligrams, frequency in hours, and total duration in days for each condition. It is a useful guide for healthcare professionals to prescribe appropriate antibiotics for these infections.*
Pediatric Dosage Guidelines (Pediatric Dosage Guidelines)
This text provides pediatric dosage guidelines for different infections, specifying the recommended doses, frequencies, and duration for children between 1 to 17 years of age. It includes dosage information for conditions such as complicated urinary tract infections, post-exposure prophylaxis, and plague. The dosages are given in milligrams per kilogram of body weight.*
Steady Pharmacokinetic (Steady Pharmacokinetic)
This is a table showing steady-state pharmacokinetic parameters for different doses of a medication in adults. The parameters include maximum concentration (max, ss) in ug/mL and area under the curve (AUC) in ugh/mL for varying doses administered orally and intravenously at different intervals. Doses range from 400 mg to 750 mg given every 8 to 12 hours.*
Ciprofloxacin-str1 (Ciprofloxacin Str1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.